Search results
Overall, 2084 (91%) patients developed SSc prior to age 65; whereas 216 (9%) were ≥65 years. Late-age onset patients had a significantly higher proportion of anti-centromere antibodies (42% vs 27%; p=0.001) compared to younger-age onset.
• Scleroderma Overview –This initial section gives a general description of the scleroderma family of diseases and discusses the affected population, possible causes, and typical symptoms. • Scleroderma Diagnosis – Diagnosing someone with scleroderma can be a lengthy
31 lip 2024 · Scleroderma, also known as systemic sclerosis, is an autoimmune connective tissue disorder characterized by multisystem fibrosis and soft tissue calcification. As such, it affects many separate organ systems, which are discussed separately: musculoskeletal manifestations of scleroderma. pulmonary manifestations of scleroderma
It is estimated that there are over 6000 people with systemic scleroderma in Australia. Statistically, approximately three to four times more women than men develop the condition. Scleroderma is found in every age group from infants to the elderly, but its onset is most frequent between the ages of 25 to 55.
The term scleroderma refers to hardened skin. There are various conditions that are affected by scleroderma or appear similar to it. Acrodermatitis chronica atrophicans. Systemic sclerosis and CRST syndrome. Mixed connective tissue disease. Porphyria cutanea tarda. Morphoea or localised scleroderma. Lipodermatosclerosis.
Scleroderma is an autoimmune, rheumatic, and chronic disease that affects the body by hardening connective tissue. Learn all about Scleroderma including signs & symptoms, diagnosis, treatment and lifestyle options.
This Guide for New and Future Patients™ is a companion document to the Scleroderma FAQ™, also available through the Scleroderma Education Project website: www.SclerodermaInfo.org. Think of the main Scleroderma FAQ as the 50-page User Manual that came with your shiny new 65-inch ultra high definition TV.
